Xeno Transplants Corp logo

Xeno Transplants Corp

XENO · OTC · Health Technology, Biotechnology · Founded 2004

Xeno Transplants Corp. operates as a bio-technology research and development company. It intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.

Current Price
$0.00
Market Cap
$4K
Return Since Last Split
-100%
Last Split
Sep 6, 2006
Total Splits
1
Cumulative Multiple
2.5×

What If You Bought XENO Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$0
250 shares · 3×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Sep 6, 2006$0.865-for-22.5×2.5×

Xeno Transplants Corp Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Xeno Transplants Corp's latest record in the split calendar is a 5-for-2 forward split effective 2006-09-06.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.